Literature DB >> 23622372

Medical and psychosocial considerations in rehabilitation care of childhood neuromuscular diseases.

Michel Vanasse1, Hélène Paré, Reinhard Zeller.   

Abstract

Most neuromuscular diseases (NMD) are rare inherited conditions presenting a relentlessly progressive course. Some NMD are associated with intellectual impairment and many are complicated by musculoskeletal, cardiac, or respiratory problems. Rehabilitation care of NMD is thus best provided by a team of medical specialists and health professionals working closely together in an interdisciplinary fashion. Rehabilitation for patients with NMD should include physical evaluation but also assessment of their ability to manage their daily activities or work and their need for assistive devices. With appropriate physical, psychological, and social support, those patients can maintain a good quality of life and an adequate level of well-being. Surgical management of musculoskeletal problems in children related to neuromuscular disorders remains a highly controversial subject. This review is based mainly on the author's personal experience with conservative and periopeporative rehabilitation care for neuromuscular diseases. A multidisciplinary approach is advocated. The importance of proactive respiratory care is emphasized. Rehabilitation after surgical treatment of spinal deformities is analyzed outlining the particular aspects in spinal muscular atrophy, Duchenne's muscular dystrophy, congenital muscular dystrophy, and congenital myopathies. A disease- specific approach is recommended as the wide variety of different neuromuscular pathologies requires careful planning of treatment strategies best managed in a team approach.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23622372     DOI: 10.1016/B978-0-444-59565-2.00019-8

Source DB:  PubMed          Journal:  Handb Clin Neurol        ISSN: 0072-9752


  6 in total

Review 1.  Reaching and grasping in autism spectrum disorder: a review of recent literature.

Authors:  Lori-Ann R Sacrey; Tamara Germani; Susan E Bryson; Lonnie Zwaigenbaum
Journal:  Front Neurol       Date:  2014-01-23       Impact factor: 4.003

2.  Burden, professional support, and social network in families of children and young adults with muscular dystrophies.

Authors:  Lorenza Magliano; Melania Patalano; Alessandra Sagliocchi; Marianna Scutifero; Antonella Zaccaro; Maria Grazia D'angelo; Federica Civati; Erika Brighina; Giuseppe Vita; Gian Luca Vita; Sonia Messina; Maria Sframeli; Marika Pane; Maria Elena Lombardo; Roberta Scalise; Adele D'amico; Giulia Colia; Michela Catteruccia; Umberto Balottin; Angela Berardinelli; Maria Chiara Motta; Corrado Angelini; Alessandra Gaiani; Claudio Semplicini; Luca Bello; Roberta Battini; Guja Astrea; Luisa Politano
Journal:  Muscle Nerve       Date:  2015-04-22       Impact factor: 3.217

3.  Family context in muscular dystrophies: psychosocial aspects and social integration.

Authors:  Lorenza Magliano; Luisa Politano
Journal:  Acta Myol       Date:  2016-10

4.  MPV promote adherence to nocturnal NIV in a Duchenne patient.

Authors:  Anna Annunziata; Antonietta Coppola; Antonella Marotta; Giuseppe Fiorentino
Journal:  Acta Myol       Date:  2020-06-01

5.  Experience in neuromuscular diseases in children and adolescents and their comorbidities in a tertiary hospital.

Authors:  J A Gascón-Navarro; J Torres-Borrego; M J De La Torre-Aguilar; J A Fernández-Ramos; J L Pérez-Navero
Journal:  Ital J Pediatr       Date:  2021-11-16       Impact factor: 2.638

6.  Natural history and genetic study of LAMA2-related muscular dystrophy in a large Chinese cohort.

Authors:  Dandan Tan; Lin Ge; Yanbin Fan; Xingzhi Chang; Shuang Wang; Cuijie Wei; Juan Ding; Aijie Liu; Shuo Wang; Xueying Li; Kai Gao; Haipo Yang; Chengli Que; Zhen Huang; Chunde Li; Ying Zhu; Bing Mao; Bo Jin; Ying Hua; Xiaoli Zhang; Bingbing Zhang; Wenhua Zhu; Cheng Zhang; Yanjuan Wang; Yun Yuan; Yuwu Jiang; Anne Rutkowski; Carsten G Bönnemann; Xiru Wu; Hui Xiong
Journal:  Orphanet J Rare Dis       Date:  2021-07-19       Impact factor: 4.123

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.